These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7917903)

  • 1. Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs.
    Siim BG; Atwell GJ; Wilson WR
    Br J Cancer; 1994 Oct; 70(4):596-603. PubMed ID: 7917903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and radiolytic reduction of 4-alkylamino-5-nitroquinoline bioreductive drugs. Relationship to hypoxia-selective cytotoxicity.
    Siim BG; Atwell GJ; Wilson WR
    Biochem Pharmacol; 1994 Oct; 48(8):1593-604. PubMed ID: 7980625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs.
    Siim BG; Atwell GJ; Anderson RF; Wardman P; Pullen SM; Wilson WR; Denny WA
    J Med Chem; 1997 Apr; 40(9):1381-90. PubMed ID: 9135035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient redox cycling of nitroquinoline bioreductive drugs due to aerobic nitroreduction in Chinese hamster cells.
    Siim BG; Wilson WR
    Biochem Pharmacol; 1995 Jun; 50(1):75-82. PubMed ID: 7605348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does DNA targeting affect the cytotoxicity and cell uptake of basic nitroquinoline bioreductive drugs?
    Siim BG; Denny WA; Wilson WR
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):311-5. PubMed ID: 8195025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bis-bioreductive agents as hypoxia-selective cytotoxins: nitracrine N-oxide.
    Wilson WR; Van Zijl P; Denny WA
    Int J Radiat Oncol Biol Phys; 1992; 22(4):693-6. PubMed ID: 1544839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771.
    Wilson WR; Moselen JW; Cliffe S; Denny WA; Ware DC
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):323-7. PubMed ID: 8195027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline].
    Skov KA; Adomat H; Doedee M; Farrell N
    Anticancer Drug Des; 1994 Apr; 9(2):103-17. PubMed ID: 8166927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drug.
    Moselen JW; Hay MP; Denny WA; Wilson WR
    Cancer Res; 1995 Feb; 55(3):574-80. PubMed ID: 7834627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The two faces of aldehyde oxidase: Oxidative and reductive transformations of 5-nitroquinoline.
    Paragas EM; Humphreys SC; Min J; Joswig-Jones CA; Jones JP
    Biochem Pharmacol; 2017 Dec; 145():210-217. PubMed ID: 28888950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins.
    Denny WA; Atwell GJ; Roberts PB; Anderson RF; Boyd M; Lock CJ; Wilson WR
    J Med Chem; 1992 Dec; 35(26):4832-41. PubMed ID: 1479583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine inhibition of the metabolic activation of a carcinogen, 4-nitroquinoline-1-oxide, in cultured Chinese hamster cells.
    Tsuda H; Yoshida D; Mizusaki S
    Carcinogenesis; 1984 Mar; 5(3):331-4. PubMed ID: 6200248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hypoxia on cytotoxicity, accumulation and DNA binding of cisplatin in Chinese hamster ovary cells.
    Matthews JB; Adomat H; Skov KA
    Anticancer Drugs; 1993 Aug; 4(4):463-70. PubMed ID: 8400349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen dependence of the cytotoxicity of the enediyne anti-tumour antibiotic esperamicin A1.
    Batchelder RM; Wilson WR; Hay MP; Denny WA
    Br J Cancer Suppl; 1996 Jul; 27():S52-6. PubMed ID: 8763846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
    Tercel M; Wilson WR; Anderson RF; Denny WA
    J Med Chem; 1996 Mar; 39(5):1084-94. PubMed ID: 8676343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells.
    Marshall RS; Rauth AM
    Cancer Res; 1988 Oct; 48(20):5655-9. PubMed ID: 3167822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation.
    Sato K; Howell JN; Greene MH; Maher VM; McCormick JJ
    Cancer Res; 1988 Sep; 48(18):5145-50. PubMed ID: 3136916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin.
    Koch CJ
    Cancer Res; 1993 Sep; 53(17):3992-7. PubMed ID: 8358728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.